Reviewed,
UniProtKB/Swiss-Prot P26367 (PAX6_HUMAN)
Last modified
November 25, 2008.
Version 110.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Paired box protein Pax-6 Alternative name(s): Oculorhombin Aniridia type II protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 422 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Transcription factor with important functions in the development of the eye, nose, central nervous system and pancreas. Required for the differentiation of pancreatic islet alpha cells By similarity. Competes with PAX4 in binding to a common element in the glucagon, insulin and somatostatin promoters. Regulates specification of the ventral neuron subtypes by establishing the correct progenitor domains By similarity. Isoform 5a appears to function as a molecular switch that specifies target genes. |
| Subcellular location | |
| Tissue specificity | Fetal eye, brain, spinal cord and olfactory epithelium. Isoform 5a is less abundant than the PAX6 shorter form. |
| Developmental stage | Expressed in the developing eye and brain. |
| Involvement in disease | Defects in PAX6 are the cause of aniridia type II (AN2) [MIM:106210]. AN2 is a bilateral panocular disorder characterized by complete or partial absence of the iris, absence of the fovea and malformations of the lens and anterior chamber. Severe age-related corneal degeneration is a frequent complication which contributes to a poor visual prognostis in aniridia. About one third of the cases are sporadic, and two thirds are familial, with autosomal dominant inheritance and high penetrance. Nearly one third of sporadic AN patients develop Wilms tumor in association with genitourinary anomalies and mental retardation (WAGR syndrome) as a consequence of heterozygous (sub)microscopic deletions of chromosome 11p13. Defects in PAX6 are a cause of Peters anomaly [MIM:604229]. Peters anomaly consists of a central corneal leukoma, absence of the posterior corneal stroma and Descemet membrane, and a variable degree of iris and lenticular attachments to the central aspect of the posterior cornea. Defects in PAX6 are a cause of ectopia pupillae [MIM:129750]. It is a congenital eye malformation in which the pupils are displaced from their normal central position. Defects in PAX6 are a cause of foveal hypoplasia [MIM:136520]. Foveal hypoplasia can be isolated or associated with presenile cataract. Inheritance is autosomal dominant. Defects in PAX6 are a cause of autosomal dominant keratitis [MIM:148190]. It is an eye disorder characterized by corneal opacification and vascularization, and by foveal hypoplasia. Defects in PAX6 are a cause of ocular coloboma [MIM:120200]; also known as uveoretinal coloboma or coloboma of iris, choroid and retina. Ocular colobomas are a set of malformations resulting from abnormal morphogenesis of the optic cup and stalk, and the fusion of the fetal fissure (optic fissure). Severe colobomatous malformations may cause as much as 10% of the childhood blindness. The clinical presentation of ocular coloboma is variable. Some individuals may present with minimal defects in the anterior iris leaf without other ocular defects. More complex malformations create a combination of iris, uveoretinal and/or optic nerve defects without or with microphthalmia or even anophthalmia. Defects in PAX6 are a cause of coloboma of optic nerve [MIM:120430]. Defects in PAX6 are a cause of bilateral optic nerve hypoplasia [MIM:165550]; also known as bilateral optic nerve aplasia. Inheritance is autosomal dominant. |
| Sequence similarities | Belongs to the paired homeobox family. Contains 1 homeobox DNA-binding domain. Contains 1 paired domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| Dynll1 | P63168 | 2 | EBI-747278,EBI-349121 | From a different organism. |
| HOMER3 | Q9NSC5 | 2 | EBI-747278,EBI-748420 | |
| TRIM11 | Q96F44 | 2 | EBI-747278,EBI-851809 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P26367-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 5a (identifier: P26367-2) Also known as: Pax6-5a; The sequence of this isoform differs from the canonical sequence as follows: 47-47: Q → QTHADAKVQVLDNQN | ||||||
| Isoform 3 (identifier: P26367-3) Also known as: Pax6-5A,6*; The sequence of this isoform is not available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 422 | 422 | Paired box protein Pax-6 | PRO_0000050185 | |||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||
| Domain | 4 – 130 | 127 | Paired | ||||||||||||||||||||||||||||||||
| DNA binding | 210 – 269 | 60 | Homeobox | ||||||||||||||||||||||||||||||||
| Compositional bias | 131 – 209 | 79 | Gln/Gly-rich | ||||||||||||||||||||||||||||||||
| Compositional bias | 279 – 422 | 144 | Pro/Ser/Thr-rich | ||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||
| Alternative sequence | 47 | 1 | Q → QTHADAKVQVLDNQN in isoform 5a. | VSP_002366 | |||||||||||||||||||||||||||||||
| Natural variant | 17 | 1 | N → S in AN2. | VAR_003808 | |||||||||||||||||||||||||||||||
| Natural variant | 18 | 1 | G → W in AN2 and Peters anomaly. | VAR_003809 | |||||||||||||||||||||||||||||||
| Natural variant | 22 – 26 | 5 | Missing in AN2; sporadic form. | VAR_008693 | |||||||||||||||||||||||||||||||
| Natural variant | 26 | 1 | R → G in Peters anomaly. | VAR_003810 | |||||||||||||||||||||||||||||||
| Natural variant | 29 | 1 | I → S in AN2; sporadic form. | VAR_008694 | |||||||||||||||||||||||||||||||
| Natural variant | 29 | 1 | I → V in AN2. | VAR_003811 | |||||||||||||||||||||||||||||||
| Natural variant | 33 | 1 | A → P in AN2; sporadic form. | VAR_008695 | |||||||||||||||||||||||||||||||
| Natural variant | 37 – 39 | 3 | Missing in AN2; sporadic form. | VAR_008696 | |||||||||||||||||||||||||||||||
| Natural variant | 42 | 1 | I → S in AN2; mild. | VAR_008697 | |||||||||||||||||||||||||||||||
| Natural variant | 43 | 1 | S → P in AN2; sporadic form. | VAR_008698 | |||||||||||||||||||||||||||||||
| Natural variant | 44 | 1 | R → Q in AN2. | VAR_003812 | |||||||||||||||||||||||||||||||
| Natural variant | 53 | 1 | V → D in Peters anomaly, congenital cataract and foveal hypoplasia; Japanese pedigrees. | VAR_008700 | |||||||||||||||||||||||||||||||
| Natural variant | 53 | 1 | V → L in AN2; mild. | VAR_008699 | |||||||||||||||||||||||||||||||
| Natural variant | 63 | 1 | T → P in AN2; mild. | VAR_008701 | |||||||||||||||||||||||||||||||
| Natural variant | 64 | 1 | G → V in foveal hypoplasia; associated with presenile cataract syndrome. | VAR_008702 | |||||||||||||||||||||||||||||||
| Natural variant | 68 | 1 | P → S in morning glory disk anomaly; significant impairment of transcriptional activation ability. | VAR_017540 | |||||||||||||||||||||||||||||||
| Natural variant | 79 | 1 | A → E in AN2; mild. | VAR_008703 | |||||||||||||||||||||||||||||||
| Natural variant | 87 | 1 | I → R in AN2; loss of activity. | VAR_003813 | |||||||||||||||||||||||||||||||
| Natural variant | 118 | 1 | P → R in nystagmus associated with a variant form of aniridia. | VAR_015065 | |||||||||||||||||||||||||||||||
| Natural variant | 119 | 1 | S → R in AN2; sporadic form. | VAR_008704 | |||||||||||||||||||||||||||||||
| Natural variant | 125 | 1 | R → C in foveal hypoplasia; isolated. | VAR_017541 | |||||||||||||||||||||||||||||||
| Natural variant | 126 | 1 | V → D in ectopia pupillae. | VAR_008705 | |||||||||||||||||||||||||||||||
| Natural variant | 128 | 1 | R → C in foveal hypoplasia; isolated. | VAR_003814 | |||||||||||||||||||||||||||||||
| Natural variant | 178 | 1 | Q → H in AN2. | VAR_003815 | |||||||||||||||||||||||||||||||
| Natural variant | 208 | 1 | R → Q in AN2; mild. | VAR_008706 | |||||||||||||||||||||||||||||||
| Natural variant | 208 | 1 | R → W in AN2. | VAR_003816 | |||||||||||||||||||||||||||||||
| Natural variant | 258 | 1 | F → S in ocular coloboma; significant impairment of transcriptional activation ability. | VAR_017542 | |||||||||||||||||||||||||||||||
| Natural variant | 292 | 1 | S → I in bilateral optic nerve hypoplasia; significant impairment of transcriptional activation ability. | VAR_017543 | |||||||||||||||||||||||||||||||
| Natural variant | 353 | 1 | S → A in AN2; familial form. | VAR_008707 | |||||||||||||||||||||||||||||||
| Natural variant | 363 | 1 | S → P in Peters anomaly. | VAR_017544 | |||||||||||||||||||||||||||||||
| Natural variant | 375 | 1 | P → Q in AN2; reduced DNA binding ability. | VAR_015066 | |||||||||||||||||||||||||||||||
| Natural variant | 378 | 1 | Q → R in optic nerve aplasia. | VAR_017545 | |||||||||||||||||||||||||||||||
| Natural variant | 381 | 1 | M → V in bilateral optic nerve hypoplasia. | VAR_017546 | |||||||||||||||||||||||||||||||
| Natural variant | 391 | 1 | T → A in bilateral optic nerve aplasia. | VAR_017547 | |||||||||||||||||||||||||||||||
| Natural variant | 422 | 1 | Q → R in AN2 and ocular anterior segment anomalies; loss of DNA binding ability. | VAR_008708 | |||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 317 | 1 | R → L in AAA59963 and AAA59962. Ref.1 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 369 | 1 | Y → C in CAE45868. Ref.4 | ||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||
| Beta strand | 6 – 8 | 3 | |||||||||||||||||||||||||||||||||
| Beta strand | 14 – 16 | 3 | |||||||||||||||||||||||||||||||||
| Helix | 23 – 34 | 12 | |||||||||||||||||||||||||||||||||
| Helix | 39 – 46 | 8 | |||||||||||||||||||||||||||||||||
| Helix | 50 – 63 | 14 | |||||||||||||||||||||||||||||||||
| Beta strand | 77 – 79 | 3 | |||||||||||||||||||||||||||||||||
| Helix | 81 – 93 | 13 | |||||||||||||||||||||||||||||||||
| Helix | 99 – 108 | 10 | |||||||||||||||||||||||||||||||||
| Turn | 114 – 116 | 3 | |||||||||||||||||||||||||||||||||
| Helix | 120 – 133 | 14 | |||||||||||||||||||||||||||||||||
| Helix | 219 – 229 | 11 | |||||||||||||||||||||||||||||||||
| Helix | 237 – 246 | 10 | |||||||||||||||||||||||||||||||||
| Helix | 251 – 275 | 25 | |||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region." Ton C.C.T., Hirvonen H., Miwa H., Weil M.M., Monaghan P., Jordan T., van Heyningen V., Hastie N.D., Meijers-Heijboer H., Drechsler M., Royer-Pokora B., Collins F.S., Swaroop A., Strong L.C., Saunders G.F. Cell 67:1059-1074(1991) [PubMed: 1684738] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene." Glaser T., Walton D.S., Maas R.L. Nat. Genet. 2:232-239(1992) [PubMed: 1345175] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | Liu J., Zhang B., Zhou Y., Peng X., Yuan J., Qiang B. Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE (ISOFORM PAX6). |
| [4] | The German cDNA consortium Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5A). Tissue: Cerebellum. |
| [5] | Wilkinson J. Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 5A). |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Lung. |
| [7] | "Two independent and interactive DNA-binding subdomains of the Pax6 paired domain are regulated by alternative splicing." Epstein J.A., Glaser T., Cai J., Jepeal L., Walton D.S., Maas R.L. Genes Dev. 8:2022-2034(1994) [PubMed: 7958875] [Abstract] Cited for: ALTERNATIVE SPLICING, DNA-BINDING. |
| [8] | "Crystal structure of the human Pax-6 paired domain-DNA complex reveals specific roles for the linker region and carboxyl-terminal subdomain in DNA binding." Xu H.E., Rould M.A., Xu W., Epstein J.A., Maas R.L., Pabo C.O. Genes Dev. 13:1263-1275(1999) [PubMed: 10346815] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 4-136. |
| [9] | "PAX6 mutations reviewed." Prosser J., van Heyningen V. Hum. Mutat. 11:93-108(1998) [PubMed: 9482572] [Abstract] Cited for: REVIEW ON VARIANTS. |
| [10] | "Solution structure of the homeobox domain of the human paired box protein PAX-6." RIKEN structural genomics initiative (RSGI) Submitted (NOV-2005) to the PDB data bank Cited for: STRUCTURE BY NMR OF 211-277. |
| [11] | "PAX6 mutations in aniridia." Hanson I.M., Seawright A., Hardman K., Hodgson S., Zaletayev D., Fekete G., van Heyningen V. Hum. Mol. Genet. 2:915-920(1993) [PubMed: 8364574] [Abstract] Cited for: VARIANT AN2 TRP-208. |
| [12] | "Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly." Hanson I.M., Fletcher J.M., Jordan T., Brown A., Taylor D., Adams R.J., Punnet H.H., van Heyningen V. Nat. Genet. 6:168-173(1994) [PubMed: 8162071] [Abstract] Cited for: VARIANT PETERS ANOMALY GLY-26. |
| [13] | "PAX6 missense mutation in isolated foveal hypoplasia." Azuma N., Nishina S., Yanagisawa H., Okuyama T., Yamada M. Nat. Genet. 13:141-142(1996) [PubMed: 8640214] [Abstract] Cited for: VARIANTS FOVEAL HYPOPLASIA CYS-125 AND CYS-128. |
| [14] | "Functional analysis of paired box missense mutations in the PAX6 gene." Tang H.K., Chao L.-Y., Saunders G.F. Hum. Mol. Genet. 6:381-386(1997) [PubMed: 9147640] [Abstract] Cited for: VARIANT AN2 ARG-87, VARIANT GLY-26. |
| [15] | "Combined SSCP/heteroduplex analysis in the screening for PAX6 mutations." Axton R., Hanson I.M., Love J., Seawright A., Prosser J., van Heyningen V. Mol. Cell. Probes 11:287-292(1997) [PubMed: 9281415] [Abstract] Cited for: VARIANT AN2 22-PRO--ARG-26 DEL. |
| [16] | "Ten novel mutations found in Aniridia." Wolf M.T.F., Lorenz B., Winterpacht A., Drechsler M., Schumacher V., Royer-Pokora B., Blankenagel A., Zabel B., Wildhardt G. Hum. Mutat. 12:304-313(1998) [PubMed: 9792406] [Abstract] Cited for: VARIANT AN2 TRP-18. |
| [17] | "Missense mutation at the C-terminus of the PAX6 gene in ocular anterior segment anomalies." Azuma N., Yamada M. Invest. Ophthalmol. Vis. Sci. 39:828-830(1998) [PubMed: 9538891] [Abstract] Cited for: VARIANT EYE MALFORMATIONS ARG-422. |
| [18] | "Missense mutations in the PAX6 gene in aniridia." Azuma N., Hotta Y., Tanaka H., Yamada M. Invest. Ophthalmol. Vis. Sci. 39:2524-2528(1998) [PubMed: 9856761] [Abstract] Cited for: VARIANTS AN2 SER-17; VAL-29; GLN-44 AND HIS-178. |
| [19] | "Missense mutation in the alternative splice region of the PAX6 gene in eye anomalie |

Clusters with